AskBio

posted on March 29, 2006 - 10:51am
The first U.S. human gene therapy trial directed at Duchenne muscular dystrophy (DMD) was launched yesterday at Columbus (Ohio) Children's Hospital, the Muscular Dystrophy Association (MDA), Children’s Hospital, and Asklepios Biopharmaceutical Inc. (AskBio) announced today.  Neurologist Jerry Mendell administered an injection of AskBio’s Biostrophin, which contains a functional gene for the...

New content is being added every day. Please check back again.